11-4999404-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004755.2(OR51L1):c.422G>A(p.Ser141Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004755.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR51L1 | NM_001004755.2 | c.422G>A | p.Ser141Asn | missense_variant | 3/3 | ENST00000641819.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR51L1 | ENST00000641819.1 | c.422G>A | p.Ser141Asn | missense_variant | 3/3 | NM_001004755.2 | P1 | ||
OR51L1 | ENST00000641624.1 | n.587+1821G>A | intron_variant, non_coding_transcript_variant | ||||||
OR51L1 | ENST00000642056.1 | n.587+1821G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251408Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135876
GnomAD4 exome AF: 0.000142 AC: 208AN: 1461894Hom.: 0 Cov.: 38 AF XY: 0.000127 AC XY: 92AN XY: 727248
GnomAD4 genome AF: 0.000125 AC: 19AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.422G>A (p.S141N) alteration is located in exon 1 (coding exon 1) of the OR51L1 gene. This alteration results from a G to A substitution at nucleotide position 422, causing the serine (S) at amino acid position 141 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at